Study on the therapeutic effect of cupping combined with antiviral therapy in children with herpetic angina and its impact on inflammatory factors
Abstract
Objective: To explore the therapeutic effect of cupping combined with antiviral therapy in children with herpetic angina and its impact on inflammatory factors. Method: A total of 112 pediatric patients with herpetic angina from June 2020 to May 2022 were selected as the study subjects, and randomly divided into two groups with 56 patients in each group using a number table method. The control group received antiviral therapy, while the observation group received cupping therapy. After 2 weeks of treatment, the patient's efficacy was evaluated, and a 6-month outpatient follow-up was completed. The time of symptom disappearance, visual analogue pain (VAS) score, myocardial enzyme spectrum, inflammatory factors, treatment safety, and recurrence rate were compared between the two groups. Result: After 2 weeks of intervention, the levels of VAS and CK-MB in both groups were reduced; The disappearance time, VAS score, and CK-MB of herpes, fever, and pharyngodynia symptoms in the observation group were lower than those in the control group (P<0.05); After 2 weeks of intervention, inflammatory factors were reduced in both groups; Observation group IL-1 β、 CSF-1、TNF- α、 The CRP level was lower than that of the control group (P<0.05); There was no statistical difference in the incidence of fatigue, myalgia, nasal burning sensation, and dizziness and nausea between the two groups during the treatment period (P>0.05); The recurrence rate in the observation group was lower than that in the control group at 3 and 6 months of follow-up after 4 weeks of treatment (P<0.05). Conclusion: Cupping combined with antiviral therapy can shorten the time for symptoms to disappear in children with herpetic angina, help alleviate pain and myocardial damage, and lower the level of inflammatory factors. Moreover, this treatment plan does not increase the incidence of adverse reactions, and the long-term recurrence rate of patients at 3 to 6 months is low, which is worth promoting and applying.
